Nick C Patel

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder
    Nick C Patel
    College of Pharmacy, Department of Psychiatry, University of Cincinnati College of Medicine, 3225 Eden Avenue, Cincinnati, OH 45267, USA
    J Child Adolesc Psychopharmacol 16:327-35. 2006
  2. ncbi Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder
    Nick C Patel
    Department of Psychiatry, University of Cincinnati, and the General Clinical Research Center and Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Ohio 45267 0004, USA
    J Child Adolesc Psychopharmacol 15:938-46. 2005
  3. ncbi Phenomenology associated with age at onset in patients with bipolar disorder at their first psychiatric hospitalization
    Nick C Patel
    College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267 0004, USA
    Bipolar Disord 8:91-4. 2006
  4. ncbi Ethnic differences in symptom presentation of youths with bipolar disorder
    Nick C Patel
    The College of Pharmacy, University of Cincinnati, OH 45267 0004, USA
    Bipolar Disord 8:95-9. 2006
  5. ncbi Diagnoses and antipsychotic treatment among youths in a public mental health system
    Nick C Patel
    Department of Pharmacy Practice, College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267 004, USA
    Ann Pharmacother 40:205-11. 2006
  6. ncbi Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders
    Nick C Patel
    The University of Cincinnati, 3225 Eden Avenue, PO Box 670004, Cincinnati, OH 45267 0004, USA
    Soc Psychiatry Psychiatr Epidemiol 41:341-6. 2006
  7. ncbi Open-label lithium for the treatment of adolescents with bipolar depression
    Nick C Patel
    College of Pharmacy and Department of Psychiatry, University of Cincinnati, OH 45267 0004, USA
    J Am Acad Child Adolesc Psychiatry 45:289-97. 2006
  8. pmc Lithium treatment effects on Myo-inositol in adolescents with bipolar depression
    Nick C Patel
    Division of Bipolar Disorders Research, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0004, USA
    Biol Psychiatry 60:998-1004. 2006
  9. ncbi Ziprasidone: efficacy and safety in patients with bipolar disorder
    Nick C Patel
    University of Cincinnati, College of Pharmacy and Department of Psychiatry, College of Medicine, 3225 Eden Avenue, PO Box 670004, Cincinnati, OH 45267 0004, USA
    Expert Rev Neurother 6:1129-38. 2006
  10. ncbi Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic
    Nick C Patel
    J Behav Health Serv Res 32:438-45. 2005

Detail Information

Publications41

  1. ncbi Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder
    Nick C Patel
    College of Pharmacy, Department of Psychiatry, University of Cincinnati College of Medicine, 3225 Eden Avenue, Cincinnati, OH 45267, USA
    J Child Adolesc Psychopharmacol 16:327-35. 2006
    ..We hypothesized that CDRS-R and HAM-D scores would be significantly correlated and both scales would be sensitive to change resulting from treatment...
  2. ncbi Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder
    Nick C Patel
    Department of Psychiatry, University of Cincinnati, and the General Clinical Research Center and Mental Health Service Line, Cincinnati Veterans Affairs Medical Center, Ohio 45267 0004, USA
    J Child Adolesc Psychopharmacol 15:938-46. 2005
    ..The aim of this study was to compare the longitudinal use of psychotropic medications in African-American and Caucasian adolescents with a diagnosis of bipolar disorder following their first psychiatric hospitalization...
  3. ncbi Phenomenology associated with age at onset in patients with bipolar disorder at their first psychiatric hospitalization
    Nick C Patel
    College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267 0004, USA
    Bipolar Disord 8:91-4. 2006
    ..To compare the clinical presentation of patients with early-onset (age <18 years) and typical-onset (age 20-30 years) bipolar disorder at the time of first hospitalization...
  4. ncbi Ethnic differences in symptom presentation of youths with bipolar disorder
    Nick C Patel
    The College of Pharmacy, University of Cincinnati, OH 45267 0004, USA
    Bipolar Disord 8:95-9. 2006
    ..To compare symptom profiles of African-American and white adolescents with a diagnosis of bipolar disorder...
  5. ncbi Diagnoses and antipsychotic treatment among youths in a public mental health system
    Nick C Patel
    Department of Pharmacy Practice, College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267 004, USA
    Ann Pharmacother 40:205-11. 2006
    ..The use of antipsychotics, namely newer atypical agents, has increased significantly in children and adolescents. It is important to examine diagnoses associated with antipsychotic treatment in youths...
  6. ncbi Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders
    Nick C Patel
    The University of Cincinnati, 3225 Eden Avenue, PO Box 670004, Cincinnati, OH 45267 0004, USA
    Soc Psychiatry Psychiatr Epidemiol 41:341-6. 2006
    ..The purpose of this naturalistic, retrospective database study was to compare symptom presentation of children and adolescents of different ethnicities with schizophrenia-spectrum disorders, and response to risperidone...
  7. ncbi Open-label lithium for the treatment of adolescents with bipolar depression
    Nick C Patel
    College of Pharmacy and Department of Psychiatry, University of Cincinnati, OH 45267 0004, USA
    J Am Acad Child Adolesc Psychiatry 45:289-97. 2006
    ..We hypothesized that patients receiving open-label treatment with lithium during a 6-week period would experience a statistically and clinically significant decrease in depressive symptoms and tolerate lithium treatment fairly well...
  8. pmc Lithium treatment effects on Myo-inositol in adolescents with bipolar depression
    Nick C Patel
    Division of Bipolar Disorders Research, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0004, USA
    Biol Psychiatry 60:998-1004. 2006
    ..This study used proton magnetic resonance spectroscopy (1H MRS) to identify the in vivo effects of lithium on myo-inositol (mI) concentrations in adolescent bipolar depression...
  9. ncbi Ziprasidone: efficacy and safety in patients with bipolar disorder
    Nick C Patel
    University of Cincinnati, College of Pharmacy and Department of Psychiatry, College of Medicine, 3225 Eden Avenue, PO Box 670004, Cincinnati, OH 45267 0004, USA
    Expert Rev Neurother 6:1129-38. 2006
    ..Ziprasidone is considered as a first-line treatment option in patients with bipolar manic or mixed episodes, with or without psychosis and displays a favorable side-effect profile...
  10. ncbi Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic
    Nick C Patel
    J Behav Health Serv Res 32:438-45. 2005
    ..Long-term prospective studies are needed to better delineate the effectiveness of different pharmacotherapeutic regimens on the long-term treatment outcomes in patients with bipolar disorder...
  11. ncbi Response and remission in adolescent mania: signal detection analyses of the young mania rating scale
    Nick C Patel
    Division of Bipolar Disorders Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267 0004, USA
    J Am Acad Child Adolesc Psychiatry 46:628-35. 2007
    ..The purpose of this study was to determine optimal criteria for defining response and remission in adolescents with acute mania...
  12. ncbi Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics
    Nick C Patel
    Division of Bipolar Disorders Research, University of Cincinnati College of Medicine, and Department of Psychiatry, Cincinnati Children s Hospital Medical Center, Ohio 45267 0004, USA
    J Child Adolesc Psychopharmacol 17:303-11. 2007
    ..The purpose of this study was to examine body mass indexes (BMI) and lipid profiles of children and adolescents hospitalized for a psychiatric illness and exposed to an atypical antipsychotic...
  13. doi Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium
    Nick C Patel
    College of Pharmacy, University of Georgia, Medical College of Georgia, Augusta, Georgia 30912 2450, USA
    J Child Adolesc Psychopharmacol 18:132-9. 2008
    ..This proton magnetic resonance spectroscopy (1H MRS) study identified the in vivo effects of lithium on N-acetyl-aspartate (NAA) concentrations in adolescent bipolar depression...
  14. ncbi Risk of neuroleptic malignant syndrome in patients with bipolar disorder: a retrospective, population-based case-control study
    Yan Chen
    Department of Pharmacy Practice and Administrative Sciences, School of Pharmacy, University of Cincinnati Medical Center, Ohio 45267 0004, USA
    Int J Psychiatry Med 39:439-50. 2009
    ..Current data regarding risk factors of neuroleptic malignant syndrome (NMS) are limited. This study aims to examine factors associated with increased risk of NMS in patients with bipolar disorder...
  15. doi Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study
    Jeffrey R Strawn
    University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA
    J Am Acad Child Adolesc Psychiatry 51:642-51. 2012
    ....
  16. ncbi Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program
    Nick C Patel
    College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA
    Med Care 44:87-90. 2006
    ..The purpose of this study was to examine physician specialty associated with antipsychotic prescribing from 1996 to 2001...
  17. doi Exposure to potentially dangerous drug-drug interactions involving antipsychotics
    Jeff Jianfei Guo
    Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of Cincinnati Medical Center, 3225 Eden Ave, Cincinnati, OH 45267, USA
    Psychiatr Serv 63:1080-8. 2012
    ..This study used a large state's Medicaid claims database to examine the proportion of patients exposed to such interactions and the risk factors associated with exposure...
  18. ncbi Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability
    Anthony DeLeon
    College of Pharmacy, University of Texas at Austin, 1 University Station, Austin, TX 78712 0124, USA
    Clin Ther 26:649-66. 2004
    ....
  19. ncbi Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder
    Jeff J Guo
    Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy and the Institute for the Study of Health, University of Cincinnati Academic Health Center, 3225 Eden Avenue, Cincinnati, OH 45267 0004, USA
    Psychiatr Serv 58:1073-8. 2007
    ..This study assessed costs among patients with bipolar disorder for treatment related to bipolar disorder and to comorbid conditions. Risk factors associated with costs were also assessed...
  20. ncbi Trends in the use of typical and atypical antipsychotics in children and adolescents
    Nick C Patel
    Department of Pharmacy Practice, University of Cincinnati, USA
    J Am Acad Child Adolesc Psychiatry 44:548-56. 2005
    ..To estimate prevalence rates of antipsychotic use in children and adolescents from 1996 to 2001 in three state Medicaid programs (midwestern [MM], southern [SM], and western [WM]) and one private managed care organization (MCO)...
  21. doi Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study
    Yan Chen
    Research Associate of Pharmacoepidemiology and Pharmacoeconomics, School of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
    Ann Pharmacother 42:177-84. 2008
    ..Given the widespread use of antidepressants and the negative consequence of cerebrovascular events (CVEs), an evaluation of the risk of CVEs associated with antidepressants is warranted...
  22. doi Utilization, price, and spending trends for antidepressants in the US Medicaid Program
    Yan Chen
    Division of Pharmacy Practice and Administrative Sciences, University of Cincinnati College of Pharmacy, 3225 Eden Avenue, Cincinnati, OH 45267 0004, USA
    Res Social Adm Pharm 4:244-57. 2008
    ..However, antidepressant utilization and price patterns within this market have not yet been adequately characterized...
  23. ncbi Antidepressant prophylaxis for poststroke depression: a meta-analysis
    Yan Chen
    Pharmacoepidemiology and Pharmacoeconomics, Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0004, USA
    Int Clin Psychopharmacol 22:159-66. 2007
    ....
  24. ncbi Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?
    Yan Chen
    Division of Pharmacy Practice and Administrative Sciences, University of Cincinnati Medical Center, Cincinnati, OH 45267 0004, USA
    Pharmacoepidemiol Drug Saf 18:196-202. 2009
    ..This study aimed to determine whether the degree of serotonin (5-HT) reuptake inhibition affects risk of hemorrhagic stroke associated with antidepressant use in patients with depression...
  25. ncbi Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy
    Nick C Patel
    Division of Pharmacy Practice, College of Pharmacy, Department of Psychiatry, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA
    Pharmacotherapy 25:1242-7. 2005
    ....
  26. doi Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations
    Lara S Picard
    Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA
    Pharmacotherapy 28:530-5. 2008
    ..In patients receiving any antipsychotic, clinicians should carefully evaluate any features of NMS and should not prematurely exclude a diagnosis of NMS in cases where severe rigidity or hyperthermia is not initially apparent...
  27. ncbi Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996 to 2000
    Nick C Patel
    College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA
    J Child Adolesc Psychopharmacol 12:221-9. 2002
    ..Male and female antipsychotic prevalence rates increased during the 5-year period. The increase in total expenditures was related to the increased utilization of atypical antipsychotics...
  28. ncbi A retrospective analysis of the short-term effects of olanzapine and quetiapine on weight and body mass index in children and adolescents
    Nick C Patel
    College of Pharmacy, University of Texas at Austin, 78712, USA
    Pharmacotherapy 24:824-30. 2004
    ..To evaluate changes in short-term weight and body mass index (BMI) in children and adolescents receiving olanzapine or quetiapine...
  29. ncbi Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents
    Floyd R Sallee
    Department of Psychiatry, College of Medicine, University of Cincinnati, OH, USA
    J Am Acad Child Adolesc Psychiatry 45:720-8. 2006
    ....
  30. ncbi Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms
    Yan Chen
    Division of Pharmacy Practice and Administrative Sciences, James L Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, OH 45267, USA
    Ann Pharmacother 42:1791-6. 2008
    ..With the exception of case reports, limited data are available regarding the risk of hepatotoxicity associated with the use of telithromycin...
  31. doi A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance
    Susan L McElroy
    aLindner Center of HOPE, Mason, Ohio and University of Cincinnati College of Medicine, Cincinnati, Ohio bDepartment of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia, USA
    Int Clin Psychopharmacol 26:48-53. 2011
    ..Further studies of ramelteon in subgroups of bipolar patients with sleep disturbance, including those with depression or euthymia, seem indicated...
  32. ncbi Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder
    Aaron P Gibson
    College of Pharmacy, The University of Texas at Austin, 78712, USA
    Ann Pharmacother 40:1134-42. 2006
    ..To identify, review, and analyze studies comparing atomoxetine with psychostimulants with the intent of determining the role of atomoxetine in the pharmacologic management of attention deficit/hyperactivity disorder (ADHD)...
  33. doi Pharmacist screening for depression among patients with diabetes in an urban primary care setting
    Dan E Knight
    College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA
    J Am Pharm Assoc (2003) 48:518-21. 2008
    ....
  34. ncbi Secretin treatment for autistic disorder: a critical analysis
    Nick C Patel
    College of Pharmacy, The University of Texas at Austin, Austin State Hospital, Texas Department of Mental Health and Retardation, 78712, USA
    Pharmacotherapy 22:905-14. 2002
    ..A number of controlled clinical trials did not show improvement in autistic symptoms with secretin compared with placebo, possibly indicating no role for the drug in autistic disorder...
  35. ncbi Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis
    Yan Chen
    Pharmacoepidemiology and Pharmacoeconomics, Department of Pharmacy Practice and Administrative Sciences, School of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH 45267 0004, USA
    Ann Pharmacother 40:2115-22. 2006
    ..Data regarding the treatment efficacy of antidepressants in patients with PSD are conflicting, and the time-dependent effects of antidepressant treatment in this population are unknown...
  36. ncbi Experience with ziprasidone
    Nick C Patel
    J Am Acad Child Adolesc Psychiatry 41:495. 2002
  37. ncbi One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics
    Nick C Patel
    Austin State Hospital, Texas Department of Mental Health and Mental Retardation, and the College of Pharmacy of the University of Texas, Austin, Texas 78712, USA
    Psychiatr Serv 53:891-3. 2002
    ..Conventional antipsychotics were associated with a lower one-year rehospitalization rate than risperidone or olanzapine...
  38. ncbi Sudden late onset of clozapine-induced agranulocytosis
    Nick C Patel
    Austin State Hospital, Texas Department of Mental Health and Mental Retardation, Austin, USA
    Ann Pharmacother 36:1012-5. 2002
    ..To report a patient who suddenly developed agranulocytosis after long-term clozapine therapy...
  39. ncbi Adverse event reporting with selective serotonin-reuptake inhibitors
    Nicole R Hartnell
    College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada
    Ann Pharmacother 37:1387-91. 2003
    ..The purpose of this study was to examine the number of adverse event reports associated with specific selective serotonin-reuptake inhibitor (SSRI) use...
  40. doi Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis
    W Burleson Daviss
    University of Texas Health Science Center at San Antonio, TX, USA
    J Am Acad Child Adolesc Psychiatry 47:189-98. 2008
    ..To examine the safety and tolerability of clonidine used alone or with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD)...
  41. ncbi Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents
    Nick C Patel
    The University of Texas at Austin, Texas Department of Mental Health and Mental Retardation, Austin, Texas 78712, USA
    J Child Adolesc Psychopharmacol 15:270-84. 2005
    ..Finally, effective interventions require the development and implementation of evidence-based treatment strategies using a multidisciplinary approach...